281 related articles for article (PubMed ID: 37777806)
1. TDP-43 pathology is associated with increased tau burdens and seeding.
Tomé SO; Tsaka G; Ronisz A; Ospitalieri S; Gawor K; Gomes LA; Otto M; von Arnim CAF; Van Damme P; Van Den Bosch L; Ghebremedhin E; Laureyssen C; Sleegers K; Vandenberghe R; Rousseau F; Schymkowitz J; Thal DR
Mol Neurodegener; 2023 Sep; 18(1):71. PubMed ID: 37777806
[TBL] [Abstract][Full Text] [Related]
2. LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease.
Koper MJ; Tomé SO; Gawor K; Belet A; Van Schoor E; Schaeverbeke J; Vandenberghe R; Vandenbulcke M; Ghebremedhin E; Otto M; von Arnim CAF; Balusu S; Blaschko MB; De Strooper B; Thal DR
Acta Neuropathol Commun; 2022 Sep; 10(1):128. PubMed ID: 36057624
[TBL] [Abstract][Full Text] [Related]
3. Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.
Smith VD; Bachstetter AD; Ighodaro E; Roberts K; Abner EL; Fardo DW; Nelson PT
Brain Pathol; 2018 Mar; 28(2):264-273. PubMed ID: 28281308
[TBL] [Abstract][Full Text] [Related]
4. Concomitant LATE-NC in Alzheimer's disease is not associated with increased tau or amyloid-β pathological burden.
McAleese KE; Walker L; Erskine D; Johnson M; Koss D; Thomas AJ; Attems J
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):722-734. PubMed ID: 32896913
[TBL] [Abstract][Full Text] [Related]
5. Limbic-Predominant Age-Related TDP-43 Encephalopathy: Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis.
Gauthreaux KM; Teylan MA; Katsumata Y; Mock C; Culhane JE; Chen YC; Chan KCG; Fardo DW; Dugan AJ; Cykowski MD; Jicha GA; Kukull WA; Nelson PT
Neurology; 2022 Apr; 98(14):e1422-e1433. PubMed ID: 35121671
[TBL] [Abstract][Full Text] [Related]
6. LATE-NC in Alzheimer's disease: Molecular aspects and synergies.
Tomé SO; Gawor K; Thal DR
Brain Pathol; 2023 Oct; 34(4):e13213. PubMed ID: 37793659
[TBL] [Abstract][Full Text] [Related]
7. Tau and TDP-43 synergy: a novel therapeutic target for sporadic late-onset Alzheimer's disease.
Latimer CS; Liachko NF
Geroscience; 2021 Aug; 43(4):1627-1634. PubMed ID: 34185246
[TBL] [Abstract][Full Text] [Related]
8. Association of glial tau pathology and LATE-NC in the ageing brain.
Forrest SL; Wagner S; Kim A; Kovacs GG
Neurobiol Aging; 2022 Nov; 119():77-88. PubMed ID: 35977443
[TBL] [Abstract][Full Text] [Related]
9. Resistance and resilience to Alzheimer's disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort.
Latimer CS; Burke BT; Liachko NF; Currey HN; Kilgore MD; Gibbons LE; Henriksen J; Darvas M; Domoto-Reilly K; Jayadev S; Grabowski TJ; Crane PK; Larson EB; Kraemer BC; Bird TD; Keene CD
Acta Neuropathol Commun; 2019 Jun; 7(1):91. PubMed ID: 31174609
[TBL] [Abstract][Full Text] [Related]
10. Neuropathology of Alzheimer's Disease.
Trejo-Lopez JA; Yachnis AT; Prokop S
Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
[TBL] [Abstract][Full Text] [Related]
11. The influence of Aβ-dependent and independent pathways on TDP-43 proteinopathy in Alzheimer's disease: a possible connection to LATE-NC.
Jamerlan A; An SSA
Neurobiol Aging; 2020 Nov; 95():161-167. PubMed ID: 32814257
[TBL] [Abstract][Full Text] [Related]
12. Elevation of casein kinase 1ε associated with TDP-43 and tau pathologies in Alzheimer's disease.
Gu J; Hu W; Tan X; Qu S; Chu D; Gong CX; Iqbal K; Liu F
Brain Pathol; 2020 Mar; 30(2):283-297. PubMed ID: 31376192
[TBL] [Abstract][Full Text] [Related]
13. Loss of TDP-43 splicing repression occurs early in the aging population and is associated with Alzheimer's disease neuropathologic changes and cognitive decline.
Chang K; Ling JP; Redding-Ochoa J; An Y; Li L; Dean SA; Blanchard TG; Pylyukh T; Barrett A; Irwin KE; Moghekar A; Resnick SM; Wong PC; Troncoso JC
Acta Neuropathol; 2023 Dec; 147(1):4. PubMed ID: 38133681
[TBL] [Abstract][Full Text] [Related]
14. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
Nelson PT; Dickson DW; Trojanowski JQ; Jack CR; Boyle PA; Arfanakis K; Rademakers R; Alafuzoff I; Attems J; Brayne C; Coyle-Gilchrist ITS; Chui HC; Fardo DW; Flanagan ME; Halliday G; Hokkanen SRK; Hunter S; Jicha GA; Katsumata Y; Kawas CH; Keene CD; Kovacs GG; Kukull WA; Levey AI; Makkinejad N; Montine TJ; Murayama S; Murray ME; Nag S; Rissman RA; Seeley WW; Sperling RA; White CL; Yu L; Schneider JA
Brain; 2019 Jun; 142(6):1503-1527. PubMed ID: 31039256
[TBL] [Abstract][Full Text] [Related]
15. The development and convergence of co-pathologies in Alzheimer's disease.
Robinson JL; Richardson H; Xie SX; Suh E; Van Deerlin VM; Alfaro B; Loh N; Porras-Paniagua M; Nirschl JJ; Wolk D; Lee VM; Lee EB; Trojanowski JQ
Brain; 2021 Apr; 144(3):953-962. PubMed ID: 33449993
[TBL] [Abstract][Full Text] [Related]
16. Distinct molecular patterns of TDP-43 pathology in Alzheimer's disease: relationship with clinical phenotypes.
Tomé SO; Vandenberghe R; Ospitalieri S; Van Schoor E; Tousseyn T; Otto M; von Arnim CAF; Thal DR
Acta Neuropathol Commun; 2020 Apr; 8(1):61. PubMed ID: 32349792
[TBL] [Abstract][Full Text] [Related]
17. The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death.
Thal DR; Tomé SO
Brain Res Bull; 2022 Nov; 190():204-217. PubMed ID: 36244581
[TBL] [Abstract][Full Text] [Related]
18. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
19. Pathological Changes of Tau Related to Alzheimer's Disease.
Chu D; Liu F
ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
[TBL] [Abstract][Full Text] [Related]
20. Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.
Dakson A; Yokota O; Esiri M; Bigio EH; Horan M; Pendleton N; Richardson A; Neary D; Snowden JS; Robinson A; Davidson YS; Mann DM
Acta Neuropathol; 2011 May; 121(5):635-49. PubMed ID: 21243369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
